Urology - urothelial cancer, Malmö
81 – 90 of 165
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
The Urothelial Transcriptomic Response to Interferon Gamma : Implications for Bladder Cancer Prognosis and Immunotherapy
(
- Contribution to journal › Article
-
Mark
Molecular pathology of the non-luminal Ba/Sq-like and Sc/NE-like classes of urothelial tumours : An integrated immunohistochemical analysis
(
- Contribution to journal › Article
-
Mark
Reply to Joep J. de Jong and Ewan A. Gibb's Letter to the Editor re: Gottfrid Sjödahl, Johan Abrahamsson, Karin Holmsten, et al. Different Responses to Neoadjuvant Chemotherapy in Urothelial Carcinoma Molecular Subtypes. Eur Urol. 2022;81:316-7. Neoadjuvant Chemotherapy Response in Muscle-invasive Bladder Cancer: Differences in Intrinsic Biology or Subtyping Nomenclature?
(
- Contribution to journal › Letter
- 2021
-
Mark
The association between meat and fish consumption and bladder cancer risk : a pooled analysis of 11 cohort studies
(
- Contribution to journal › Article
-
Mark
Thromboembolism in Muscle-Invasive Bladder Cancer. A Population-based Nationwide Study
(
- Contribution to journal › Article
-
Mark
Impact of treatment delay in acute myeloid leukemia revisited
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Survival after radical cystectomy during holiday periods
(
- Contribution to journal › Article
-
Mark
Risk prediction for renal cell Carcinoma : Results from the European Prospective Investigation into Cancer and nutrition (EPIC) prospective cohort study
(
- Contribution to journal › Article
-
Mark
A population-based study on the effect of a routine second-look resection on survival in primary stage T1 bladder cancer
(
- Contribution to journal › Article
-
Mark
When the Molecular Subtype Is Hidden Behind a Veil of Stroma
(
- Contribution to journal › Debate/Note/Editorial